EA201100154A1 - Способ лечения заболеваний толстой кишки - Google Patents

Способ лечения заболеваний толстой кишки

Info

Publication number
EA201100154A1
EA201100154A1 EA201100154A EA201100154A EA201100154A1 EA 201100154 A1 EA201100154 A1 EA 201100154A1 EA 201100154 A EA201100154 A EA 201100154A EA 201100154 A EA201100154 A EA 201100154A EA 201100154 A1 EA201100154 A1 EA 201100154A1
Authority
EA
Eurasian Patent Office
Prior art keywords
rifalazil
intestines
colon
treating diseases
bacterial infection
Prior art date
Application number
EA201100154A
Other languages
English (en)
Inventor
Шалом Саяда
Original Assignee
ЭКТИВБАЙОТИКС ФАРМА, ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЭКТИВБАЙОТИКС ФАРМА, ЭлЭлСи filed Critical ЭКТИВБАЙОТИКС ФАРМА, ЭлЭлСи
Publication of EA201100154A1 publication Critical patent/EA201100154A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)

Abstract

Предложены способы лечения бактериальной инфекции в толстой кишке и кишечных расстройств, вызванных бактериальной инфекцией, с применением плохо абсорбируемой формы рифалазила. Композиции для орального введения и доставки в толстую кишку не микрогранулированного состава на основе рифалазила также предусмотрены. Рифалазил доставляется в форме, которая плохо абсорбируется в кишечнике после орального дозирования и большая часть введенного орально рифалазила не абсорбируется в кишечнике. Соответственно, антибактериальная активность в кишечной флоре будет увеличиваться, в то время как абсорбция и системная циркуляция будут уменьшаться, тем самым приводя к уменьшению возникновения возможных неблагоприятных эффектов.
EA201100154A 2008-07-07 2009-06-30 Способ лечения заболеваний толстой кишки EA201100154A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7844308P 2008-07-07 2008-07-07
PCT/US2009/049288 WO2010005836A2 (en) 2008-07-07 2009-06-30 Use of rifalazil to treat colonic disorders

Publications (1)

Publication Number Publication Date
EA201100154A1 true EA201100154A1 (ru) 2011-08-30

Family

ID=41507676

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201100154A EA201100154A1 (ru) 2008-07-07 2009-06-30 Способ лечения заболеваний толстой кишки

Country Status (8)

Country Link
US (1) US20110117154A1 (ru)
EP (1) EP2313099A4 (ru)
CN (1) CN102143751A (ru)
BR (1) BRPI0910496A2 (ru)
CA (1) CA2730274A1 (ru)
EA (1) EA201100154A1 (ru)
MX (1) MX2011000319A (ru)
WO (1) WO2010005836A2 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1400989B1 (it) * 2010-07-13 2013-07-05 Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
EP2776829A4 (en) 2011-11-08 2015-05-27 Univ Texas METHODS AND USES OF METABOLIC PROFILING FOR DIFFICULT CLOSTRIDIUM INFECTION (CDI)
US9758838B2 (en) 2013-03-12 2017-09-12 Yale University Compositions and methods for identifying secretory antibody-bound microbes
WO2016033439A2 (en) 2014-08-28 2016-03-03 Yale University Compositions and methods for the treating an inflammatory disease or disorder
US20170258816A1 (en) 2014-09-12 2017-09-14 Antibiotx Aps Antibacterial Use of Halogenated Salicylanilides
CN104644572B (zh) * 2015-01-27 2017-10-03 华北制药股份有限公司 一种高纯度克林霉素磷酸酯粉针剂及其制备工艺
GB201509326D0 (en) * 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
AU2017343886B2 (en) * 2016-10-14 2023-07-06 Cipla Limited Pharmaceutical compositions comprising rifaximin
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1304363C (en) * 1988-11-01 1992-06-30 Takehiko Yamane 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
US5547683A (en) * 1992-10-09 1996-08-20 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Method for producing microgranulated particle
WO2003051300A2 (en) * 2001-12-13 2003-06-26 Activbiotics, Inc. Metal complexes and formulations of rifamycin analogues and uses therof
WO2004019907A1 (en) * 2002-08-29 2004-03-11 Activbiotics, Inc. Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics

Also Published As

Publication number Publication date
CA2730274A1 (en) 2010-01-14
EP2313099A2 (en) 2011-04-27
EP2313099A4 (en) 2011-08-10
BRPI0910496A2 (pt) 2016-08-02
US20110117154A1 (en) 2011-05-19
WO2010005836A3 (en) 2010-05-20
WO2010005836A9 (en) 2010-04-01
CN102143751A (zh) 2011-08-03
WO2010005836A2 (en) 2010-01-14
MX2011000319A (es) 2011-09-29

Similar Documents

Publication Publication Date Title
EA201100154A1 (ru) Способ лечения заболеваний толстой кишки
EA201290171A1 (ru) Вводимые перорально кортикостероидные композиции
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
MX344476B (es) Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal.
EA201590836A1 (ru) Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием
EP3904502A3 (en) Compositions and methods
EA201100305A1 (ru) Лечение респираторных заболеваний
EA201171088A1 (ru) Лечение дискинезии при различных расстройствах
BR112012016543A2 (pt) Tratamento com vb-201
EP2043637A4 (en) METHOD AND MEDICAMENTS FOR THE ADMINISTRATION OF IBUPROFEN
EP2575456A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ECCHYMOSIS
JP2014505679A5 (ru)
BRPI0602179A (pt) composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
NZ602032A (en) Oral b12 therapy
MX2014003093A (es) Combinacion de pterostilbeno y estatina para el tratamiento de enfermedad metabolica, enfermedad cardiovascular e inflamacion.
BR112015028581A2 (pt) composição farmacêutica de dosagem baixa, utilização do ácido, método para o tratamento da doença inflamatória e composição farmacêutica
MY163107A (en) Pharmaceutical composition for the treatment of bladder disorders
RU2011108787A (ru) Способ лечения больных красным плоским лишаем слизистой полости рта
RU2008151796A (ru) Способ профилактики желудочно-кишечных заболеваний у поросят-отъемышей
EA201592261A1 (ru) Фармацевтические композиции, включающие агомелатин в форме сокристаллов агомелатина с органической кислотой
WO2009140457A3 (en) Combinations of antioxidants and anti-inflammatory drugs in the of treatment inflammatory bowel disease
RU2008140019A (ru) Способ лечения и профилактики эндометритов у коров
UA38103U (ru) Способ определения побочного действия антибактериальных препаратов
RU2008107113A (ru) Средство и способ профилактики и лечения пациентов с болезнью альцгеймера
RU2007138452A (ru) Способ лечения пушных зверей при отодектозе